Bausch + Lomb recalls some of its implantable eye lenses
Bausch + Lomb employs more than 1,500 people at its contact lens manufacturing plant in Waterford.
Bausch + Lomb has said it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.
The company said it was recalling these lenses, which are part of its enVista platform, out of an abundance of caution, and was looking to identify a root cause.
Headquartered in Canada, the company employs more than 1,500 people at its contact lens manufacturing plant in the IDA Business Park on Waterford's Cork Road. The company recently invested an additional €90m to expand its capabilities in its Waterford plant.
"As much as we believe in the enVista platform, patient safety will always be our number one priority," chief executive Brent Saunders said.
The company's intraocular or surgically implanted lenses are used in cataract surgery to replace the natural clouded lens in the eye.
Bausch + Lomb said there had been reports of an inflammatory reaction in some patients with these lenses, adding the patients responded quickly to treatment, with none requiring removal of the lens.
The company said it was informing eye care professionals about the impacted lots and return protocols for the product.
